A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease
Clinical trial NCT02431468 · COMPLETED
Trial details
- NCT number
- NCT02431468
- Sponsor
- Neurotrope Bioscience, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-02-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.